<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 12 May 2026 13:04:51 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/sparktherapeutics/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Roche's $4.3 billion purchase of Spark Therapeutics approved by US antitrust]]></title><description><![CDATA[Swiss drugmaker Roche has been approved by US antitrust to buy gene therapy specialist Spark Therapeutics in a $4.3 billion deal. This move allows Roche to advance its push in treating rare diseases like]]></description><link>http://direct.ecency.com/roche/@coinstore/news-x1tv5ojjxd-h7t4t3diaqm</link><guid isPermaLink="true">http://direct.ecency.com/roche/@coinstore/news-x1tv5ojjxd-h7t4t3diaqm</guid><category><![CDATA[roche]]></category><dc:creator><![CDATA[coinstore]]></dc:creator><pubDate>Tue, 17 Dec 2019 09:00:33 GMT</pubDate><enclosure url="https://images.ecency.com/p/4PYjjVwJ1UdtVsi5b9TvrUHMFCXnZ3yTKwoDeL4kYQZBLfbYXp5YogQK8UST4iBy71AzgAFbYoJnAQWzdQDd8cexxXWnbGo9ZMphMZipP7B?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>